C-reactive protein (CRP) and procalcitonin (PCT) are commonly used to differentiate between bacterial infections with other inflammatory conditions [6], but it is unclear how this can be applied to COVID-19 to guide antimicrobial management. Here, CRP is linked to bacterial infectious disease.